Figure: Enhancement of viral
HA binding affinity for the
S28H mutant.
Figure: Increased in vivo neutralization potency of the
S28H variant.
Figure: Less dramatic pathological changes in the lungs of the
S28H-treated mice were detected One-way ANOVA was used t
Figure: Virus titres were substantially reduced in the
S28H-treated group compared to HNIgGA6-treated and the control mice.
IV mutation literature information.
PMID: 
2020
Frontiers in microbiology
Browser Board
Co-occurred Entities
Filtrator